Details for New Drug Application (NDA): 021355
✉ Email this page to a colleague
The generic ingredient in ANGELIQ is drospirenone; estradiol. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the drospirenone; estradiol profile page.
Summary for 021355
Tradename: | ANGELIQ |
Applicant: | Bayer Hlthcare |
Ingredient: | drospirenone; estradiol |
Patents: | 1 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 021355
Generic Entry Date for 021355*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 021355
Mechanism of Action | Estrogen Receptor Agonists |
Suppliers and Packaging for NDA: 021355
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ANGELIQ | drospirenone; estradiol | TABLET;ORAL | 021355 | NDA | Bayer HealthCare Pharmaceuticals Inc. | 50419-482 | 50419-482-03 | 3 BLISTER PACK in 1 CARTON (50419-482-03) / 28 TABLET, FILM COATED in 1 BLISTER PACK (50419-482-01) |
ANGELIQ | drospirenone; estradiol | TABLET;ORAL | 021355 | NDA | Bayer HealthCare Pharmaceuticals Inc. | 50419-482 | 50419-482-72 | 1 BLISTER PACK in 1 CARTON (50419-482-72) / 14 TABLET, FILM COATED in 1 BLISTER PACK (50419-482-71) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.25MG;0.5MG | ||||
Approval Date: | Feb 29, 2012 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 22, 2031 | Product Flag? | Y | Substance Flag? | Delist Request? |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG;1MG | ||||
Approval Date: | Sep 28, 2005 | TE: | RLD: | Yes |
Expired US Patents for NDA 021355
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Hlthcare | ANGELIQ | drospirenone; estradiol | TABLET;ORAL | 021355-002 | Sep 28, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription